AndroGel Cost in Arizona 2026: Cash Pay, Insurance, Medicaid, and Compounded Alternatives

What Does AndroGel Actually Cost in Arizona in 2026?

Branded AndroGel 1.62% carries an AbbVie wholesale acquisition cost near $510 per month in 2026, but almost nobody pays that figure. The real out-of-pocket cost depends on insurance tier, manufacturer assistance, pharmacy choice, and whether a prescriber substitutes a compounded or generic formulation. Arizona retail cash-pay prices for 30 g testosterone gel 1.62% range from about $180 to $260 per month through discount programs such as GoodRx at Fry's, Costco, and Walgreens locations in Phoenix, Tucson, and Flagstaff.

The FDA approved the original AndroGel 1% formulation in 2000 for adult males with primary or hypogonadotropic hypogonadism, and the 1.62% concentration received approval in 2011. The current prescribing information is maintained in the FDA Drugs@FDA database. Hypogonadism affects an estimated 2 to 4% of men, with prevalence rising sharply after age 40. [1]

Testosterone replacement with AndroGel has Level 1 evidence behind it. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies (N=788 men aged 65 or older with serum testosterone <275 ng/dL), demonstrated that testosterone gel increased sexual activity, walking distance, and bone mineral density vs. placebo at 12 months. [2] The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed on at least two morning serum testosterone measurements <300 ng/dL. [3]

As the guideline states: "We recommend testosterone therapy for men with symptomatic androgen deficiency to induce and maintain secondary sex characteristics and to improve their sexual function, sense of well-being, muscle mass and strength, and bone mineral density." [3]

Generic testosterone gel (1% and 1.62% concentrations from multiple manufacturers) entered the Arizona market after 2015, pulling street prices measurably lower than the branded product for patients paying cash.

How Arizona Insurance Plans Handle AndroGel Coverage

Commercial insurance in Arizona generally covers testosterone gel, though prior authorization requirements and tier placement vary by plan. Most major Arizona carriers, including Blue Cross Blue Shield of Arizona, UnitedHealthcare Arizona, and Cigna, place generic testosterone gel on Tier 2 or Tier 3 of their formularies. Branded AndroGel sits on Tier 3 or Tier 4 in many plans, meaning copays can range from $60 to $150 per month after deductible with a standard commercial plan.

Prior authorization (PA) is common. Typical PA criteria require documented serum testosterone below a threshold (often <300 ng/dL on two morning samples), a confirmed diagnosis code of hypogonadism (ICD-10 E29.1), and evidence of at least one symptom such as reduced libido, fatigue, or decreased muscle mass. [4] Some plans additionally require a trial-and-failure of generic testosterone gel before approving branded AndroGel.

Medicare Part D covers testosterone gel, but plan-specific formulary placement differs. Patients on Arizona Medicare Advantage plans should check their Summary of Benefits or call the plan's pharmacy line. The Medicare Plan Finder at CMS.gov can display exact cost-sharing for a given ZIP code. [5]

A 2021 analysis published in JAMA Internal Medicine examined out-of-pocket costs for testosterone therapy across commercial payers and found that cost-sharing burden was highest among patients on high-deductible health plans, where annual out-of-pocket costs for testosterone replacement could exceed $1,200. [6] Arizona has a relatively high penetration of high-deductible plan enrollment through ACA Marketplace plans, making manufacturer assistance cards especially relevant.

Arizona Medicaid (AHCCCS): No Coverage for Male Hypogonadism

Arizona Medicaid, administered through the Arizona Health Care Cost Containment System (AHCCCS), does not cover AndroGel or other testosterone preparations for male hypogonadism as of 2026. This exclusion applies to both branded AndroGel and generic testosterone gel when the indication is adult-onset hypogonadism in males.

AHCCCS does cover testosterone for certain oncologic indications (for example, metastatic breast cancer) and for gender-affirming hormone therapy under the Arizona Gender-Affirming Care policy adopted in recent years. Men with documented hypogonadism secondary to a covered condition (such as pituitary adenoma) may be able to obtain coverage with additional documentation, but standard age-related testosterone decline does not qualify. [7]

Patients enrolled in AHCCCS-contracted managed care organizations, including UnitedHealthcare Community Plan and Mercy Care, face the same exclusion at the MCO level. An appeal citing medical necessity may succeed if a prescriber documents a specific secondary cause of hypogonadism rather than a primary idiopathic diagnosis. The AHCCCS Medical Policy Manual, Chapter 900, governs pharmacy benefit exclusions. [7]

For AHCCCS-enrolled men who do not qualify for coverage, compounded testosterone gel at $120 per month represents the most accessible cash-pay option. Some Arizona federally qualified health centers (FQHCs) also dispense testosterone at 340B program prices, which can significantly reduce cost for low-income patients who meet eligibility criteria. [8]

The AbbVie myAbbVie Assist Savings Card: How It Works in Arizona

AbbVie operates two assistance programs for AndroGel. The myAbbVie Assist copay card is for commercially insured patients and can reduce the monthly copay to $0 for eligible individuals, subject to a maximum annual benefit. The myAbbVie Assist patient assistance program provides free medication to uninsured or underinsured patients who meet income thresholds (generally at or below 400% of the federal poverty level). [9]

The copay card cannot be used with federal or state government insurance programs, including Medicare, Medicaid, Tricare, or AHCCCS. Arizona residents on AHCCCS are therefore ineligible for the card. Commercially insured Arizona patients can activate the card at the AbbVie website or through their prescribing clinician's office, and most Arizona retail pharmacies can process it at the point of sale. [9]

Patients using the AbbVie myAbbVie Assist patient assistance program receive medication shipped directly to their home or physician's office. Processing typically takes 3 to 4 weeks for initial approval. Documentation required includes proof of income, a copy of the prescription, and confirmation that no government insurance is in force.

The copay card benefit resets annually on January 1. Arizona patients who hit the annual cap mid-year should contact AbbVie directly at the number on the card to explore bridge options or transition to the patient assistance program. [9]

Compounded Testosterone Gel in Arizona: Legal, Regulated, and Cheaper

Compounded testosterone gel from a 503A compounding pharmacy is legal in Arizona. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to prepare patient-specific compounded medications on the basis of a valid prescription from a licensed practitioner. [10] Arizona Board of Pharmacy-licensed compounding pharmacies in Phoenix, Scottsdale, Tucson, and other metro areas routinely prepare testosterone gel in concentrations ranging from 1% to 10%.

The typical price for a 503A-compounded testosterone gel in Arizona runs about $120 per month, less than one-quarter the branded AndroGel list price. Pharmacies set their own pricing, so actual costs vary by concentration, base (hydroalcoholic gel vs. PLO vs. lipoderm), and quantity dispensed. [10]

503B outsourcing facilities operate under stricter FDA oversight than 503A pharmacies, are registered with the FDA, and may compound testosterone without patient-specific prescriptions for office use. Both 503A and 503B pathways are legal in Arizona provided the pharmacy holds appropriate licensure. [11]

The HealthRX clinical team uses a three-tier cost framework when counseling Arizona hypogonadism patients on testosterone gel options:

Tier 1 (Lowest cost, $80, $130/month): Compounded testosterone gel from a local 503A pharmacy or via a telehealth-connected compounding pharmacy. Appropriate for cash-pay patients, AHCCCS enrollees, and those who fail to meet PA criteria for brand or generic.

Tier 2 (Mid cost, $0, $150/month): Generic testosterone gel 1.62% or 1% through commercial insurance with a GoodRx or manufacturer coupon as a fallback. Best for patients with commercial coverage and a Tier 2 formulary placement.

Tier 3 (Brand, variable cost): Branded AndroGel with AbbVie copay card for commercially insured patients who require the brand-specific device or whose insurer will not substitute generic. Out-of-pocket with the card is often $0, $30/month, but the card is unavailable to Medicare and AHCCCS enrollees.

One clinical nuance: compounded testosterone gel is not FDA-approved and has not undergone the same bioequivalence testing as generic testosterone gel, which the FDA requires to demonstrate bioequivalence to the branded reference listed drug. [12] Clinicians should monitor serum total testosterone 4 to 6 weeks after initiating any compounded formulation and adjust the dose accordingly.

Generic Testosterone Gel vs. Branded AndroGel in Arizona

FDA-approved generic testosterone gel 1.62% (from manufacturers including Teva and Perrigo) underwent bioequivalence testing against AndroGel 1.62% before approval. [12] Generics must deliver 90 to 111% of the brand's peak and total testosterone exposure, per FDA bioequivalence standards.

At Arizona retail pharmacies, generic testosterone gel 1.62% costs approximately $200, $350 per month cash. That is still 30 to 50% below branded AndroGel without discounts, but more than twice the price of compounded gel. GoodRx, RxSaver, and SingleCare coupons can pull generic gel prices to roughly $180 per month at high-volume Arizona retailers such as Costco in Tempe or Fry's Marketplace pharmacies in the Phoenix metro. [13]

A 2020 study in the Journal of the Endocrine Society (N=112 men) found no statistically significant difference in steady-state serum testosterone levels between branded AndroGel 1.62% and an FDA-approved generic at equivalent doses after 8 weeks of use. Mean serum testosterone in the generic cohort was 489 ng/dL vs. 501 ng/dL in the branded cohort (P<0.40). [14] Both values fall within the normal eugonadal range of 300, 1 to 000 ng/dL per Endocrine Society guidance. [3]

Prescribers in Arizona can write "Dispense as Written" (DAW) on a prescription if they require the branded product. Without DAW, Arizona pharmacists are permitted (and in many cases contractually required by PBMs) to substitute a generic. Patients who prefer branded AndroGel because of the metered-pump delivery system should ask their prescriber to note that preference explicitly.

Telehealth and AndroGel Prescribing in Arizona

Telehealth prescribing of testosterone gel is permitted in Arizona. However, testosterone is a Schedule III controlled substance under the DEA Controlled Substances Act, which means prescribing remotely is subject to the DEA's telemedicine rules. [15]

Under the DEA's 2023 interim final rule and subsequent 2024 amendments, prescribers may issue a Schedule III controlled substance to a patient they have never seen in person only if the patient has had a prior in-person medical evaluation with any DEA-registered practitioner, or if a qualifying telemedicine platform holds a special registration. [15] Practically, this means many Arizona telehealth companies offering testosterone therapy require a one-time in-person lab draw and clinical assessment before issuing a testosterone prescription remotely. Labs must confirm hypogonadism (serum total testosterone <300 ng/dL on two morning fasting samples) and rule out secondary causes before initiation. [3]

Arizona-based telehealth platforms and national TRT clinics operating in Arizona (such as HealthRX, Maximus, Defy Medical, and others) generally follow this workflow: online intake, local lab order, provider video visit, prescription sent to a compounding or retail pharmacy. Turnaround from first contact to prescription can be 5, 10 business days when labs are already on file. [16]

The Arizona Telemedicine Act (A.R.S. § 36-3601 et seq.) establishes that a valid patient-provider relationship can be formed via telemedicine, including for prescribing, provided the standard of care is met. [16] Arizona does not require an in-person visit specifically for testosterone, but federal DEA rules add the layer described above.

Application of Testosterone Gel: Dosing and Monitoring Basics

AndroGel 1.62% is applied once daily to the shoulders and upper arms. Starting dose is typically 40.5 mg (2 pump actuations or one unit-dose packet), with adjustment to 20.25 mg or up to 81 mg based on serum testosterone measured 14 days after initiation or dose change. [17]

The Endocrine Society guideline targets a serum total testosterone in the mid-normal range (400 to 700 ng/dL) during replacement therapy. [3] Monitoring should include serum testosterone at 3 and 6 months after initiation, then annually. Hematocrit should be checked at baseline, 3 to 6 months, and annually because testosterone therapy raises erythropoiesis. [3] A hematocrit above 54% warrants dose reduction or temporary discontinuation.

Transfer of testosterone to partners or children via skin-to-skin contact is a documented safety risk. The FDA added a black box warning for this secondary exposure risk in 2009. [17] Patients should allow the application site to dry completely, wash hands thoroughly, and cover the application site with clothing before any contact with others.

A 12-month randomized controlled trial published in the New England England Journal of Medicine (N=493, the TTrials sexual function trial) found that testosterone gel increased the percentage of men reporting improved sexual desire from 43% at baseline to 64% at 12 months vs. 43% to 49% in the placebo group (P<0.001). [2] Bone mineral density data from the TTrials bone trial showed a mean increase of 3.5% in lumbar spine BMD in the testosterone group vs. 1.0% in placebo (P<0.001). [2]

What Drives Price Variation at Arizona Pharmacies?

Pharmacy-level price variation for testosterone gel in Arizona can be $80 to $120 per month even within the same city. Several factors explain the spread.

Pharmacy Benefit Manager (PBM) contracts determine the maximum allowable cost (MAC) for generic drugs. Chains such as CVS (which also owns Caremark PBM) may price generics higher than independent pharmacies or warehouse clubs. Costco pharmacy in Arizona does not require a paid membership to use the pharmacy and consistently prices generic testosterone gel competitively. [13]

340B pricing is available at FQHCs and certain hospital outpatient pharmacies. Eligible low-income patients can access testosterone gel at 340B prices, which can be 25 to 50% below standard cash-pay. The Health Resources and Services Administration (HRSA) maintains the 340B database for covered entities. [8]

Drug discount cards (GoodRx, RxSaver, NeedyMeds, WellRx) negotiate separate rates with pharmacies. These cards cannot be combined with insurance in most cases, so patients should compare their insured copay against the GoodRx cash price before deciding which to present at the counter. In some Arizona cases, the GoodRx cash price for generic testosterone gel is lower than a commercial insurance copay.

A 2022 analysis in Health Affairs (N=9,200 prescriptions) found that patients who used GoodRx for testosterone gel paid a median of $184 per month vs. $231 per month using commercial insurance, a 20% savings attributable to PBM spread pricing. [18]

Safety Considerations for Long-Term Testosterone Gel Use in Arizona

Testosterone therapy carries risks that every prescriber and patient should weigh before initiating treatment. The FDA prescribing information for AndroGel lists cardiovascular risk, polycythemia, sleep apnea exacerbation, infertility, and prostate issues as adverse effects of concern. [17]

Cardiovascular outcomes remain debated. The TRAVERSE trial (N=5,246 men aged 45, 80 with hypogonadism and pre-existing or high risk of cardiovascular disease) found that testosterone replacement was non-inferior to placebo for major adverse cardiovascular events (MACE) over a median 33-month follow-up: incidence of MACE was 7.0% in the testosterone group vs. 7.3% in placebo (P<0.001 for non-inferiority). [19] The trial was published in the New England Journal of Medicine in 2023 and represents the largest cardiovascular outcomes trial for testosterone therapy to date.

Infertility is a meaningful concern for younger Arizona men on testosterone gel. Exogenous testosterone suppresses LH and FSH via hypothalamic-pituitary feedback, reducing intratesticular testosterone and spermatogenesis. Men wishing to preserve fertility should discuss alternatives such as clomiphene citrate or human chorionic gonadotropin (hCG) with their prescriber before starting testosterone gel. [3]

The Endocrine Society guideline states: "We recommend against starting testosterone therapy in patients who are planning fertility in the near term." [3] Sperm counts may take 6 to 18 months to recover after testosterone cessation, and recovery is not guaranteed.

Step-by-Step: Getting AndroGel or Testosterone Gel in Arizona in 2026

1. Order a morning fasting serum total testosterone test (ideally before 10 AM) through a local Arizona lab (Quest, LabCorp, Sonora Quest).
2. If total testosterone is <300 ng/dL, repeat the test on a separate morning to confirm. Add LH, FSH, CBC, PSA, and metabolic panel.
3. Schedule a visit with a primary care physician, urologist, endocrinologist, or telehealth provider licensed in Arizona.
4. Discuss the three-tier cost framework. Confirm insurance formulary status before the prescription is sent.
5. If using compounded gel, confirm the compounding pharmacy holds an active Arizona Board of Pharmacy 503A license.
6. Activate the AbbVie myAbbVie Assist card at the pharmacy counter if using branded AndroGel with commercial insurance.
7. Return for serum testosterone at 4 to 6 weeks after starting any new formulation.

Check serum testosterone, hematocrit, and PSA at 3 months, 6 months, and annually thereafter per Endocrine Society monitoring guidance. [3]